Your session is about to expire
← Back to Search
Metformin DR for Type 2 Diabetes (DREAM-T2D Trial)
DREAM-T2D Trial Summary
This trial is testing whether Metformin DR, which is designed to release metformin slowly in the small intestine, can improve glycemic control in T2DM patients with different levels of renal function safely.
- Type 2 Diabetes
DREAM-T2D Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowDREAM-T2D Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DREAM-T2D Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is Metformin DR's usual purpose?
"Metformin DR is most commonly taken as a preventative measure for type 2 diabetes. However, it can also be used to treat other medical conditions like type 1 diabetes mellitus, diabetic ketoacidosis, and polycystic ovary syndrome."
Are elderly patients being considered for this clinical trial?
"This trial allows anyone that meets the age requirements of 18 or older and 100 or younger to participate."
Has Metformin DR undergone FDA approval?
"Metformin DR is a Phase 3 trial medication, meaning that while there is some data supporting its efficacy, there is also multiple rounds of data supporting safety. Our team rates it as a 3 on our 1-to-3 scale."
Are research subjects still being enrolled in this experiment?
"This is an active clinical trial, as seen on the website clinicaltrials.gov. The original posting date was 5/18/2021, with the most recent update being 6/7/2022."
Is the data on Metformin DR conclusive?
"As of now, there are 45 ongoing Phase 3 trials and 180 total live studies investigating Metformin DR. Most of these investigations taking place in Rockville, Maryland; although, 1952 different locations across the world are running clinical trials for Metformin DR."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger